276 related articles for article (PubMed ID: 8916730)
1. Interferon beta in multiple sclerosis.
Richards RG
BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
[No Abstract] [Full Text] [Related]
2. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
Cardy P
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939142
[No Abstract] [Full Text] [Related]
3. Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis.
Forbes RB; Lees A; Waugh N; Swingler RJ
BMJ; 1999 Dec; 319(7224):1529-33. PubMed ID: 10591710
[TBL] [Abstract][Full Text] [Related]
4. Trial of interferon-beta in multiple sclerosis stopped early.
Bonn D
Lancet; 1998 Feb; 351(9102):573. PubMed ID: 9492786
[No Abstract] [Full Text] [Related]
5. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
Longthorne PN
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939141
[No Abstract] [Full Text] [Related]
6. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau J; White R
Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
[No Abstract] [Full Text] [Related]
7. [Interferon-beta in multiple sclerosis--who is going to be treated?].
Aarli JA
Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3114. PubMed ID: 10522472
[No Abstract] [Full Text] [Related]
8. The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.
Rice G
Arch Neurol; 2001 Aug; 58(8):1297-8. PubMed ID: 11493173
[No Abstract] [Full Text] [Related]
9. Beta interferon and multiple sclerosis: why the fuss?
Mumford CJ
QJM; 1996 Jan; 89(1):1-3. PubMed ID: 8730337
[No Abstract] [Full Text] [Related]
10. Treatment of multiple sclerosis with interferon beta-1 b.
Abdul-Ahad A; Shah S; Galazka A
Neurology; 1997 Aug; 49(2):641-2. PubMed ID: 9270626
[No Abstract] [Full Text] [Related]
11. Shortcomings in pharmacy benefit forecasting--interferon beta products.
Rich SJ; Meyer C
J Manag Care Pharm; 2003; 9(4):373; author reply 374. PubMed ID: 14613461
[No Abstract] [Full Text] [Related]
12. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
Chellingsworth M
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939140
[No Abstract] [Full Text] [Related]
13. Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.
Bryant J; Clegg A; Milne R
BMJ; 2000 May; 320(7247):1474-5; author reply 1475-6. PubMed ID: 10877569
[No Abstract] [Full Text] [Related]
14. Why interferon beta 1b was licensed is a mystery.
Harvey P
BMJ; 1996 Aug; 313(7052):297-8. PubMed ID: 8704553
[No Abstract] [Full Text] [Related]
15. [Immunotherapy of multiple sclerosis. Consensus and controversies].
Hohlfeld R
Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989
[No Abstract] [Full Text] [Related]
16. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
Blake G; Murphy S
Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
[No Abstract] [Full Text] [Related]
17. Bad decision NICE.
Ellis SJ
Lancet; 2002 Feb; 359(9304):447. PubMed ID: 11844551
[No Abstract] [Full Text] [Related]
18. [A short history of beta-interferon therapy of multiple sclerosis].
Stock G; Horowski R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
[TBL] [Abstract][Full Text] [Related]
19. A cost-utility analysis of interferon beta for multiple sclerosis.
Parkin D; McNamee P; Jacoby A; Miller P; Thomas S; Bates D
Health Technol Assess; 1998; 2(4):iii-54. PubMed ID: 9580870
[No Abstract] [Full Text] [Related]
20. Newer long-term treatments for multiple sclerosis.
Pryse-Phillips W
Clin Neurol Neurosurg; 2002 Jul; 104(3):265-71. PubMed ID: 12127666
[No Abstract] [Full Text] [Related]
[Next] [New Search]